Titan Medical Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

DEPRECIATION AND AMORTIZATION

DEPRECIATION AND AMORTIZATION

9 Months Ended

Sep. 30, 2022

Disclosure of depreciation and amortization expense [Abstract]

8.DEPRECIATION AND AMORTIZATION

The following table shows depreciation and amortization expense included in Research and Development (R&D) and General and Administrative (G&A) expenses:

	Three Months Ended				Nine Months Ended
	Sept 30, 2022		Sept 30, 2021		Sept 30, 2022		Sept 30, 2021
	$		$			$		$
Depreciation of ROU assets		87		85		259		218
Depreciation of PPE		87		43		202		104
R&D - Depreciation		174		128		461		322
G&A - Amortization of patent rights		40		40		102		81
Depreciation and Amortization		214		168		563		403